News
Elevance Health projects Q1 earnings beat, confirms 2025 outlook despite high Medicare Advantage costs
For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023. Profits for the full year were also on par with 2023, according to the report, with the company earning $5.98 billion in profit for 2024 compared to $5.987 billion in 2023.
Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Peter Haytaian; Executive ...
Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health ...
Elevance Health brought in $2.2 billion in profit for the first quarter of 2025, a figure that surpassed Wall Street's ...
Elevance Health saw net income fall 2.9% to $2.2 billion during the first quarter, the insurer announced Tuesday.
In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Elevance Health Inc. (NYSE: ELV) ended the first quarter of 2025 with better-than-expected financials. The company identified home health as one of its ...
Elevance Health, Inc.'s Q1 results showed stable Medicare utilization and reaffirmed guidance, in contrast to sector volatility following UnitedHealth Group's rough earnings miss. Medicaid ...
Elevance Health (ELV) came out with quarterly earnings of $11.97 per share, beating the Zacks Consensus Estimate of $11.21 per share. This compares to earnings of $10.64 per share a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback